Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

32.33

-1.59 (-4.69%)

At close: Mar 20, 2026, 4:00 PM EDT

32.57

+0.24 (0.74%)

After-hours: Mar 20, 2026, 7:58 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-359.64	-109.96	-85.9	-68.87	-54.99
Depreciation & Amortization	0.43	0.35	0.29	0.29	0.3
Stock-Based Compensation	40.82	29.71	16.75	8.67	6.1
Other Adjustments	-9.27	-17.25	-8.07	1.32	3.94
Changes in Accounts Payable	43.44	2.3	-1.02	7.09	-2.54
Changes in Accrued Expenses	6.17	5.82	-1.82	5.81	-0.51
Changes in Other Operating Activities	-0.63	1.24	6.38	-2.71	0.12
Operating Cash Flow	-278.69	-87.79	-73.38	-48.4	-47.59
Purchases of Investments	-418.04	-1,113	-478.3	-121.43	-168.02
Proceeds from Sale of Investments	759.43	560	299.22	176.18	205.98
Investing Cash Flow	341.39	-553.37	-179.09	54.75	37.96
Issuance of Common Stock	76.44	654.57	278.5	12.49	7.59
Repurchase of Common Stock	-	-42.1	-7.12	-8.33	-0.71
Net Common Stock Issued (Repurchased)	76.44	612.46	271.38	4.16	6.88
Financing Cash Flow	76.44	612.46	271.38	4.16	6.88
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.01	-0.15	-0.03	-0.26	-
Net Cash Flow	139.14	-28.69	18.91	10.52	-2.75
Free Cash Flow	-278.69	-87.79	-73.38	-48.4	-47.59
Free Cash Flow Per Share	-2.47	-0.81	-0.78	-0.63	-0.62
Levered Free Cash Flow	-310.23	-100.26	-82.06	-58.39	-57.62
Unlevered Free Cash Flow	-343.93	-141.21	-96.99	-59.88	-58.31

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q